Digest Network How does it work
Network
/
Society
Ba
Not verified

Bayer

What we write about

BiotechnologyHealthIndustriaMedicine - variousPharmaceuticals

109 Press releases

View all press releases
04/12/2025
Scienza
Biotechnology
Pharmaceuticals
Health
Food hygiene
Medicine - various
Sanità
Industria
Bayer Starts Phase IIa Study for Treatment of Patients With Alport Syndrome
Source
Bayer
Issuer
Business Wire
1.00
0
03/12/2025
Eventi
Industria
Scienza
Medical and health
Medicine - various
Biotechnology
Nuclear medicine
Pharmaceuticals
Health
RSNA25: Pediatric Study for Bayer's Investigational MRI Contrast Agent Gadoquatrane Meets Primary and Secondary Endpoints
Source
Bayer
Issuer
Business Wire
1.00
0
02/12/2025
Industria
Scienza
Medical and health
Medicine - various
Sanità
Biotechnology
Pharmaceuticals
Windows / Shopping
Health
Bayer Starts New Phase III Study with Mirena® for the Treatment of Nonatypical Endometrial Hyperplasia
Source
Bayer
Issuer
Business Wire
1.00
0
02/12/2025
Bayer Crop Science Canada Launches EverGol Rise for Enhanced User Experience in Pulse Disease Control
Source
Bayer
Issuer
Business Wire
1.00
0
02/12/2025
Law
Scienza
Agriculture
Raw materials
Pharmaceuticals
Health
Associations / Professional
Bayer Welcomes Solicitor General Support for U.S. Supreme Court Review
Source
Bayer
Issuer
Business Wire
1.00
0
01/12/2025
Food hygiene
Sanità
Pharmaceuticals
Health
Bayer’s MEDRAD® Centargo Multi-Patient CT Injection System Now With A Wider Range of Compatible CT Contrast Agents and Presentations
Source
Bayer
Issuer
Business Wire
1.00
0
23/11/2025
Industria
Food hygiene
Health
Medicine - various
Pharmaceuticals
Cardiology
Biotechnology
Bayer’s Asundexian Met Primary Efficacy and Safety Endpoints in Landmark Phase III OCEANIC-STROKE Study in Secondary Stroke Prevention
Source
Bayer
Issuer
Business Wire
1.00
0
20/11/2025
Scienza
Food hygiene
Medicine - various
Biotechnology
Sanità
Pharmaceuticals
Health
Optics
Oncology
Industria
U.S. FDA Approves HYRNUO® (sevabertinib) for Previously Treated Patients with HER2-Mutated Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Source
Bayer
Issuer
Business Wire
1.00
0
10/11/2025
Scienza
Biotechnology
Sanità
Health
Fitness / Wellness
Industria
Bayer Launches “Science Delivers” Campaign Celebrating the Transformative Power of Science
Source
Bayer
Issuer
Business Wire
1.00
0
06/11/2025
Biotechnology
Sanità
Fitness / Wellness
Health
Labour market
Dr. Judith Hartmann to Become New Chief Financial Officer of Bayer AG
Source
Bayer
Issuer
Business Wire
1.00
0

Contact details

Social Media

Followers
0
Compatibility
0